Literature DB >> 3032476

The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography.

S Kaul, W Glasheen, T D Ruddy, N G Pandian, A E Weyman, R D Okada.   

Abstract

Because the left ventricular "area at risk" is the most important determinant of ultimate infarct size, it would be useful to know the size of the area at risk during acute myocardial infarction to make therapeutic decisions. We therefore performed a series of experiments in four groups of dogs. In group I dogs (n = 15) we attempted to determine whether current methods of assessing left ventricular function during acute myocardial infarction reflect the true size of the area at risk. At each of two to five sequential stages, a more proximal coronary occlusion was performed to produce a larger area at risk until cardiovascular collapse occurred. At each stage, the area at risk (measured by myocardial contrast echocardiography), hemodynamic variables, and left ventricular ejection fraction (LVEF) were measured. Hemodynamic variables became abnormal when the area at risk was large (25% to 40% of the left ventricle), whereas LVEF became abnormal when the area at risk was of moderate size (18%). When cardiac output and LVEF were normalized to baseline values, a close inverse relationship was noted between these variables and area at risk. In contrast, there was a poor relationship between normalized mean arterial pressure and area at risk (r = .42). In group II dogs (n = 9) the area at risk was measured serially over 6 hr after coronary occlusion. The size of the area at risk remained unchanged regardless of the transmural extent of the ultimate infarct. The circumferential endocardial extent of the area at risk closely predicted the circumferential endocardial extent of the infarct at 6 hr in eight of nine dogs that developed an infarct. Group III dogs (n = 7) underwent the same protocol as group II dogs, but the duration of occlusion was 3 hr. The circumferential endocardial extent of the area at risk closely predicted the circumferential endocardial extent of the infarct. Group IV dogs (n = 5) underwent subtotal coronary occlusion. Although regional wall motion abnormalities were noted in this group, no area at risk could be defined. We conclude that although a close inverse relationship is noted between normalized cardiac output and area at risk, the absolute values for cardiac output and other hemodynamic variables become abnormal only when the area at risk is large (25% to 40%); measurement of LVEF may provide a better assessment of the size of the area at risk than hemodynamic variables.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032476     DOI: 10.1161/01.cir.75.6.1249

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Added value of contrast echocardiography in assessing myocardial viability.

Authors:  A Nagy; F L Dini; D Rovai
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Clinical methods to determine coronary flow and myocardial perfusion.

Authors:  M J Wolters-Geldof; V M Cats; A V Bruschke
Journal:  Int J Card Imaging       Date:  1997-04

3.  Sonicated X-ray contrast agents for quantitative myocardial contrast echocardiography--a critical approach.

Authors:  I V Mayer; M P Lazarov; U Utzinger; A U Freiburghaus; O M Hess
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

4.  Combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after acute reperfused myocardial infarction.

Authors:  F Leclercq; P Messner-Pellenc; Q Descours; J P Daures; J L Pasquié; F X Hager; J M Davy; R Grolleau-Raoux
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

Review 5.  Effects of nicorandil on regional perfusion and left ventricular function.

Authors:  M Schlepper; J Thormann; K Berwing; R Strasser; V Mitrovic
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

6.  Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury.

Authors:  James J Ley; Ricardo Prado; Jian Qin Wei; Nanette H Bishopric; David A Becker; Myron D Ginsberg
Journal:  Biochem Pharmacol       Date:  2007-09-08       Impact factor: 5.858

Review 7.  Myocardial Contrast Echocardiography in the Evaluation of Hypertensive Heart Disease.

Authors:  Ernest C Madu; Chiranjivi Potu; Dainia Baugh; Edwin Tulloch-Reid
Journal:  Cardiol Res       Date:  2011-11-20

8.  Value of adenosine infusion for infarct size determination using real-time myocardial contrast echocardiography.

Authors:  Paulo Magno Martins Dourado; Jeane Mike Tsutsui; Antonio Carlos Palandri Chagas; João César Nunes Sbano; Vera Demarchi Aiello; Protásio Lemos da Luz; Wilson Mathias; Jose A F Ramires
Journal:  Cardiovasc Ultrasound       Date:  2006-02-08       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.